OPTIMA-ID:为智力障碍的老年人开发和验证药物优化工具
Juliette O'Connell1, Ashleigh Gorman2, Éilish Burke2
1School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.
Expert review of clinical pharmacology
|August 14, 2024
概括
开发了一个新工具OPTIMA-ID,以优化智力障碍老年人的药物,解决独特的处方需求. 该工具包含67个标准,以改善该群体的药物管理.
科学领域:
- 老年人药理学 老年人药理学
- 智力障碍研究 智力障碍研究
- 医疗保健服务研究 医疗服务研究
背景情况:
- 智力障碍的老年人面临着独特的药物挑战,包括高比例的不适当处方.
- 优化处方的现有工具并不适合这个特定的人群.
- 需要一个专门的工具来解决智力障碍的老年人的药物管理问题.
研究的目的:
- 开发一个全面的工具,优化药物治疗和改善药物治疗智力障碍老龄化 (OPTIMA-ID),用于优化智力障碍老年人的药物治疗.
- 创建一个基于文献,临床专业知识和利益相关者的投入的工具.
主要方法:
- 使用文献审查和临床专业知识创建了一个工具草案.
- 专注组与医疗保健专业人员和智力残疾人共同改进了该工具.
- 一个专家小组使用了Delphi方法进行电子验证,就处方标准达成共识.
主要成果:
- 在两个Delphi轮之后,在OPTIMA-ID工具的67个规定标准上达成共识.
- 在第一轮中,共商定了63个标准,在第二轮中又接受了4个标准.
结论:
- OPTIMA-ID工具包括67个标准,旨在优化智力残疾老年人的药物治疗.
- 需要进一步的研究来确定该工具的有效性,可行性和对患者结果的影响.
更多相关视频
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.7K
11:29Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
Published on: June 20, 2020
9.1K
相关概念视频
Cognitive Development During Adulthood
72
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
72
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Analysis of Population Pharmacokinetic Data
241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241
